P. Pellegrin, D. Morlat, J. Neau, R. Pellegrin, D. S. Thiébaut et al., Composition of the GECSA: Epidemiology and biostatistics Clinical and biological hospital units:Bo rd ea uxUn i ve r sity Hospital, Pr M

. Gemain, Libourne Hospital

D. Witte, C. Dr, M. Courtault, M. Blaizeau, V. Bruyand et al., Pau Hospital Périgueux Hospital Villeneuve-sur-Lot Hospital: Dr I. Chossat. Permanent team

J. Kaulich-bartz, W. Dam, M. May, B. Lederberger, U. Widmer et al., Writing Committee for the Antiretroviral Therapy Cohort C: Insurability of HIV-positive people treated with antiretroviral therapy in Europe: collaborative analysis of HIV cohort studies, AIDS, vol.2013, issue.10, pp.271641-1655

C. Lewden, T. May, E. Rosenthal, C. Burty, F. Bonnet et al., Changes in causes of death among adults infected by HIV between" surveys (ANRS EN19 and Mortavic), J Acquir Immunodefic Syndr, issue.5, pp.48590-598, 2000.
URL : https://hal.archives-ouvertes.fr/inserm-00337877

S. Berry, J. Fleishman, R. Moore, and K. Gebo, Trends in reasons for hospitalization in a multisite United States cohort of persons living with HIV, J Acquir Immune Defic Syndr, vol.2012, issue.594, pp.368-375, 2001.

A. Mocroft, P. Reiss, J. Gasiorowski, B. Ledergerber, J. Kowalska et al., Serious Fatal and Nonfatal Non-AIDS-Defining Illnesses in Europe, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.55, issue.2, pp.262-270, 2010.
DOI : 10.1097/QAI.0b013e3181e9be6b

A. Pacheco, S. Tuboi, S. May, L. Moreira, L. Ramadas et al., Temporal Changes in Causes of Death Among HIV-Infected Patients in the HAART Era in Rio de Janeiro, Brazil, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.51, issue.5, pp.51624-630, 2009.
DOI : 10.1097/QAI.0b013e3181a4ecf5

A. Mocroft, P. Reiss, J. Gasiorowski, B. Ledergerber, J. Kowalska et al., Analysis of serious non- AIDS events among HIV-infected adults at Latin American sites, HIV Med, vol.11, issue.9, pp.554-564, 2010.

K. Buchacz, R. Baker, A. Moorman, J. Richardson, K. Wood et al., Rates of hospitalizations and associated diagnoses in a large multisite cohort of HIV patients in the United States, AIDS, issue.11, pp.221345-1354, 1994.

B. Yehia, J. Fleishman, L. Wilson, P. Hicks, T. Gborkorquellie et al., Incidence of and risk factors for bacteraemia in HIV-infected adults in the era of highly active antiretroviral therapy, HIV Medicine, vol.17, issue.51(Suppl 2), pp.535-543, 2010.
DOI : 10.1111/j.1468-1293.2011.00919.x

X. Anglaret, A. Minga, D. Gabillard, T. Ouassa, E. Messou et al., AIDS and Non-AIDS Morbidity and Mortality Across the Spectrum of CD4 Cell Counts in HIV-Infected Adults Before Starting Antiretroviral Therapy in Cote d'Ivoire, Clinical Infectious Diseases, vol.54, issue.5, pp.714-723
DOI : 10.1093/cid/cir898

R. Thiebaut, P. Morlat, H. Jacqmin-gadda, D. Neau, M. P. Dabis et al., Clinical progression of HIV-1 infection according to the viral response during the first year of antiretroviral treatment. Groupe d'Epidemiologie du SIDA en Aquitaine (GECSA), AIDS, issue.8, pp.14971-978, 2000.

B. Grinsztejn, V. Veloso, R. Friedman, R. Moreira, P. Luz et al., Early mortality and cause of deaths in patients using HAART in Brazil and the United States, AIDS, vol.23, issue.16, pp.232107-2114, 2009.
DOI : 10.1097/QAD.0b013e32832ec494

K. Liang and S. Zeger, Longitudinal data analysis using generalized linear models, Biometrika, vol.73, issue.1, pp.13-22, 1986.
DOI : 10.1093/biomet/73.1.13

G. Ballinger, Using Generalized Estimating Equations for Longitudinal Data Analysis, Organizational Research Methods, vol.7, issue.2, pp.127-150, 2004.
DOI : 10.1007/BF02221007

B. Grinsztejn, V. Veloso, J. Pilotto, D. Campos, J. Keruly et al., Comparison of Clinical Response to Initial Highly Active Antiretroviral Therapy in the Patients in Clinical Care in the United States and Brazil, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.45, issue.5
DOI : 10.1097/QAI.0b013e3180decb6a

J. Molina, J. Andrade-villanueva, J. Echevarria, P. Chetchotisakd, J. Corral et al., Once-Daily Atazanavir/Ritonavir Compared With Twice-Daily Lopinavir/Ritonavir, Each in Combination With Tenofovir and Emtricitabine, for Management of Antiretroviral-Naive HIV-1-Infected Patients: 96-Week Efficacy and Safety Results of the CASTLE Study, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.53, issue.3
DOI : 10.1097/QAI.0b013e3181c990bf

B. Grinsztejn, B. Nguyen, C. Katlama, J. Gatell, A. Lazzarin et al., Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial, The Lancet, vol.369, issue.9569, pp.3691261-1269, 2007.
DOI : 10.1016/S0140-6736(07)60597-2

C. Katlama, R. Esposito, J. Gatell, J. Goffard, B. Grinsztejn et al., Efficacy and safety of TMC114/ritonavir in treatment-experienced HIV patients: 24-week results of POWER 1, AIDS, vol.21, issue.4, pp.395-402, 2007.
DOI : 10.1097/QAD.0b013e328013d9d7

E. Dejesus, J. Rockstroh, J. Lennox, M. Saag, A. Lazzarin et al., Efficacy of Raltegravir Versus Efavirenz When Combined With Tenofovir/ Emtricitabine in Treatment-Na??ve HIV-1???Infected Patients: Week-192 Overall and Subgroup Analyses From STARTMRK, HIV Clinical Trials, vol.13, issue.4, pp.228-232
DOI : 10.1093/cid/cir510

B. Hasse, B. Ledergerber, H. Furrer, M. Battegay, B. Hirschel et al., Morbidity and Aging in HIV-Infected Persons: The Swiss HIV Cohort Study, Clinical Infectious Diseases, vol.53, issue.11, pp.531130-1139, 2011.
DOI : 10.1093/cid/cir626

N. Crum-cianflone, G. Grandits, S. Echols, A. Ganesan, M. Landrum et al., Trends and Causes of Hospitalizations Among HIV-Infected Persons During the Late HAART Era: What Is the Impact of CD4 Counts and HAART Use?, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.54, issue.3, pp.248-257, 2010.
DOI : 10.1097/QAI.0b013e3181c8ef22

A. Japiassu, R. Amancio, E. Mesquita, D. Medeiros, H. Bernal et al., Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients, Critical Care, vol.14, issue.4, p.152, 2010.
DOI : 10.1186/cc9221

S. Lang, M. Mary-krause, A. Simon, M. Partisani, J. Gilquin et al., HIV Replication and Immune Status Are Independent Predictors of the Risk of Myocardial Infarction in HIV-Infected Individuals, Clinical Infectious Diseases, vol.55, issue.4, pp.600-607
DOI : 10.1093/cid/cis489

K. Gebo, M. Diener-west, and R. Moore, Hospitalization Rates Differ by Hepatitis C Status in an Urban HIV Cohort, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.34, issue.2, pp.165-173, 2003.
DOI : 10.1097/00126334-200310010-00006

A. Mocroft, A. Monforte, O. Kirk, M. Johnson, N. Friis-moller et al., Changes in hospital admissions across Europe: 1995-2003. Results from the EuroSIDA study, hospital admissions across Europe: 1995?2003. Results from the EuroSIDA study, pp.437-447, 2004.
DOI : 10.1111/j.1468-1293.2004.00250.x

C. Nunez-fernandez, L. Martin-carbonero, M. Valencia, J. Aguilera, J. Garcia-samaniego et al., Liver Complications Have Reached a Plateau as Cause of Hospital Admission and Death in HIV Patients in Madrid, AIDS Research and Human Retroviruses, vol.25, issue.4, pp.383-385, 2009.
DOI : 10.1089/aid.2008.0242

F. Bonnet, C. Burty, C. Lewden, D. Costagliola, T. May et al., Changes in cancer mortality among HIV-infected patients: the Mortalite, Survey. Clin Infect Dis, issue.5, pp.48633-639, 2005.

M. Herida, M. Mary-krause, R. Kaphan, J. Cadranel, I. Poizot-martin et al., Incidence of Non???AIDS-Defining Cancers Before and During the Highly Active Antiretroviral Therapy Era in a Cohort of Human Immunodeficiency Virus???Infected Patients, Journal of Clinical Oncology, vol.21, issue.18, pp.3447-3453, 2003.
DOI : 10.1200/JCO.2003.01.096

N. Crum-cianflone, K. Hullsiek, V. Marconi, A. Weintrob, A. Ganesan et al., Trends in the incidence of cancers among HIV-infected persons and the impact of antiretroviral therapy: a 20-year cohort study, AIDS, vol.23, issue.1, pp.41-50, 2009.
DOI : 10.1097/QAD.0b013e328317cc2d

G. Clifford, L. M. Franceschi, S. Egger, M. Bouchardy, C. Korol et al., Schoni-Affolter F: Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection, Br J Cancer, vol.2012, issue.1063, pp.447-452

M. Guiguet, F. Boue, J. Cadranel, J. Lang, E. Rosenthal et al., Effect of immunodeficiency, HIV viral load, and antiretroviral therapy on the risk of individual malignancies (FHDH-ANRS CO4): a prospective cohort study, The Lancet Oncology, vol.10, issue.12, pp.101152-1159, 2009.
DOI : 10.1016/S1470-2045(09)70282-7

K. Sigel, J. Wisnivesky, K. Gordon, R. Dubrow, A. Justice et al., HIV as an independent risk factor for incident lung cancer, AIDS, vol.26, issue.8, pp.261017-1025
DOI : 10.1097/QAD.0b013e328352d1ad

F. Shebl, E. Engels, J. Goedert, and A. Chaturvedi, Pulmonary Infections and Risk of Lung Cancer Among Persons With AIDS, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.55, issue.3, pp.375-379, 2010.
DOI : 10.1097/QAI.0b013e3181eef4f7

A. Benard, F. Bonnet, J. Tessier, H. Fossoux, M. Dupon et al., Tobacco Addiction and HIV Infection: Toward the Implementation of Cessation Programs. ANRS CO3 Aquitaine Cohort, AIDS Patient Care and STDs, vol.21, issue.7, pp.458-468, 2007.
DOI : 10.1089/apc.2006.0142
URL : https://hal.archives-ouvertes.fr/inserm-00168599

L. Elzi, D. Spoerl, J. Voggensperger, D. Nicca, M. Simcock et al., A smoking cessation programme in HIV-infected individuals: a pilot study, Antivir Ther, vol.11, issue.6, pp.787-795, 2006.

P. Leutscher, C. Stecher, M. Storgaard, and C. Larsen, Discontinuation of efavirenz therapy in HIV patients due to neuropsychiatric adverse effects, Scandinavian Journal of Infectious Diseases, vol.72, issue.8, pp.45645-651
DOI : 10.1097/QAD.0b013e3283416873

E. Lanoy, M. Mary-krause, P. Tattevin, I. Perbost, I. Poizot-martin et al., Costagliola D: Frequency, determinants and consequences of delayed access to care for HIV infection in France, Antivir Ther, vol.12, issue.1, pp.89-96, 2007.

R. Moreira, P. Luz, C. Struchiner, M. Morgado, V. Veloso et al., Immune Status at Presentation for HIV Clinical Care in Rio de Janeiro and Baltimore, JAIDS Journal of Acquired Immune Deficiency Syndromes, vol.57, pp.171-178, 2011.
DOI : 10.1097/QAI.0b013e31821e9d59

G. Guaraldi, G. Orlando, S. Zona, M. Menozzi, F. Carli et al., Premature age-related comorbidities among HIVinfected persons compared with the general population, Clin Infect Dis, issue.11, pp.531120-1126, 2011.

T. Torres, S. Cardoso, V. Lde, S. Marins, L. et al., Aging with HIV: an overview of an urban cohort in Rio de Janeiro (Brazil) across decades of life, The Brazilian Journal of Infectious Diseases, vol.17, issue.3, pp.324-331
DOI : 10.1016/j.bjid.2012.10.024